Pergolide

Pergolide is a medication that used to help treat Parkinson's disease and high prolactin levels. However, it was stopped in some places because it could cause heart valve problems. It's not used anymore for these conditions.

Brand names:Celance, Permax
Medication

What people taking Pergolide report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Pergolide

What It's For

Pergolide is a Parkinson's disease medicine that is no longer sold for people in the United States. Under the brand name Permax and as a generic, it was approved in 1988 as an add-on to levodopa and carbidopa, the standard Parkinson's treatment, to help control tremor, stiffness and slowness of movement. In 2007 the manufacturers withdrew it from the US market at the request of the Food and Drug Administration (FDA) because it was linked to serious damage to the heart valves. The main reason people come across pergolide today is as a horse medicine. In the US it is sold by veterinary prescription, under brand names including Prascend, to treat pituitary pars intermedia dysfunction (often called equine Cushing's disease), a hormone disorder of older horses. Those tablets are labeled not for use in humans. For people with Parkinson's disease, other dopamine agonists that have not been linked to heart valve damage are available. In Europe, regulators reviewed pergolide in 2008 and kept it available there only as a second-choice option with heart monitoring and a lower maximum dose.

How It Works

In Parkinson's disease, the brain gradually loses cells that make dopamine, a chemical messenger needed for smooth, controlled movement. Pergolide is a dopamine agonist: rather than replacing dopamine, it directly stimulates the brain's dopamine receptors and acts in its place. Taken alongside levodopa, it allowed some people to lower their levodopa dose while keeping their movement symptoms at least as well controlled. Pergolide is chemically related to ergot, a group of compounds originally derived from a grain fungus. Ergot-type dopamine agonists also act on serotonin pathways, which researchers link to scar-like thickening (fibrosis) that stiffens the heart valves so they no longer close tightly. Newer dopamine agonists that are not ergot derivatives do not carry this valve risk. Pergolide also lowers prolactin, a hormone that controls breast milk production.

Dosage & Administration

When pergolide was prescribed for people, it was a tablet usually taken three times a day. Doctors started with a very small dose and raised it slowly over several weeks, partly because low blood pressure and dizziness were most likely early on. The levodopa dose was often lowered as pergolide was increased. Anyone still taking pergolide, for example from a source outside the US, should not stop it suddenly. Stopping a dopamine agonist abruptly can bring on confusion and hallucinations, and in rare cases a dangerous reaction with high fever, severe muscle stiffness and confusion that needs urgent medical assessment. The FDA's advice when it was withdrawn was to talk with a doctor and either switch to another dopamine agonist or taper the dose gradually. Veterinary pergolide doses are calculated for a horse's body weight and do not apply to people.

Side Effects

In clinical trials, the most common problems with pergolide added to levodopa were involuntary movements (dyskinesia), nausea, dizziness, constipation, a runny nose and sleepiness. Hallucinations occurred in about 1 in 7 people, compared with about 1 in 30 on placebo, and were a frequent reason for stopping. Older adults were more prone to confusion, sleepiness and ankle swelling. Light-headedness on standing up was most common at the start of treatment. Some people fell asleep during ordinary activities, including driving, sometimes without feeling drowsy beforehand and sometimes a year or more after starting. New episodes of falling asleep are a reason to stop driving and contact the prescriber. The serious risk that ended pergolide's US use is heart valve damage. In a 2007 study of people with Parkinson's disease, about 23% of those taking pergolide had moderate to severe leaking of at least one heart valve, compared with about 6% of people not taking a dopamine agonist and none of those taking non-ergot dopamine agonists. Leaking valves can cause shortness of breath, tiredness and a racing or pounding heartbeat; these are worth reporting promptly. Similar scarring can, less often, affect the lining of the lungs or heart or the tissue at the back of the abdomen.

Interactions & Warnings

Medicines that block dopamine work against pergolide and can worsen Parkinson's symptoms. These include most antipsychotic medicines and metoclopramide (Reglan), a drug for nausea and slow stomach emptying. Other sedating medicines can add to pergolide's sleepiness. Pergolide should not be used by anyone who has had a reaction to an ergot medicine, and in Europe it is not used in people who already have heart valve problems. Because pergolide is now mostly found in homes with horses, accidental exposure matters. Tablets should be stored away from human medicines and out of reach of children and pets. Swallowing even one can cause vomiting, dizziness, drowsiness and low blood pressure; if a person swallows a tablet, seek medical advice right away and bring the package or label. Splitting or crushing tablets can irritate the eyes or cause a headache, so the label advises not crushing them. People who are pregnant or breastfeeding are advised to wear gloves when handling the tablets, because pergolide lowers prolactin and could interfere with milk production.

What to Expect

In the US, no one starts pergolide for Parkinson's disease today. People who were taking it in 2007 were switched to other treatments, usually another dopamine agonist, or had it tapered off. Valve problems that had already developed sometimes improved after pergolide was stopped, but not always, so someone with a past history of pergolide use may want their doctor to know about it, particularly if they have breathlessness or a heart murmur. Where pergolide has remained available for people, as in Europe after the 2008 review, it is reserved for people whose Parkinson's disease cannot be managed with other options. Treatment there involves an echocardiogram (an ultrasound scan of the heart that shows how well the valves open and close) before starting and at regular intervals afterward, and stopping the medicine if the valves show new damage. For horse owners, pergolide is a long-term daily medicine for the horse, and the main human considerations are safe storage and careful handling.

Questions to Ask Your Doctor

  1. 1.I took pergolide in the past; should I have an echocardiogram to check my heart valves?
  2. 2.Which dopamine agonist or other Parkinson's treatment would suit me instead of pergolide, and how would we switch safely?
  3. 3.Could any of my current medicines, such as an antipsychotic or a nausea medicine, be making my Parkinson's symptoms worse?
  4. 4.I handle my horse's pergolide tablets while pregnant or breastfeeding; what precautions should I take?

Last reviewed • Oct 2026

Educational content, not medical advice.